Trials / Completed
CompletedNCT01594060
Basal Bolus vs. Sliding Scale for Treatment of Diabetic Patients in Medical Wards
A Randomized, Comparative Study of Basal-bolus Insulin Versus Conventional Sliding-scale Regular Insulin Therapy in Management of Non-critically Ill Patients Hospitalized in the Medical Ward.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- HaEmek Medical Center, Israel · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
A comparison of two treatment approaches for hyperglycemia in diabetic patients hospitalized in the medical department. The first approach is called basal-bolus in which 4 insulin shots are given daily ( 3 short acting before meals and one long acting before bed time). The second approach is called sliding scale in which short acting insulin alone is given before meals and before bed time according to the patient's glucose values. The aim is to keep fasting glucose between 140-180 mg/dl.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Insulin, regular - act rapid | 4 shots of regular insulin: 3 before meals and one at bedtime. |
| DRUG | Insulin glulisine, Insulin glargine | 1 shot glargine at bedtime 3 shots glulisine before meals |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2014-10-01
- Completion
- 2014-10-01
- First posted
- 2012-05-08
- Last updated
- 2018-02-28
Source: ClinicalTrials.gov record NCT01594060. Inclusion in this directory is not an endorsement.